SEC Form 4 · accession 0001181431-15-005383
Sagent Pharmaceuticals, Inc. · SGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Yordon
Director
Period of report
Feb 27, 2015
Accepted (ET)
Apr 1, 2015 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2015 | G | 48,850 | $0.00 | D | 616,076 | D | |
| Common StockF1 | holding | — | — | — | 48,850 | I | See Footnote | |
| Common Stock | holding | — | — | — | 21,088 | I | By grantor retained annuity trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares held by a member of Mr. Yordon's immediate family sharing the same household.